Site intended for UK
audience
Site intended for UK
audience
Petinimid® contains the active substance ethosuximide.
Ethosuximide is used to treat so-called “small seizures” (petit mal with absences).
In mixed forms of epilepsy, ethosuximide is used to eliminate the petit mal component.
Ethosuximide can be administered together with other anticonvulsants to achieve an appropriate therapeutic success in mixed forms of epilepsy.
| Strength | Pack size |
| 250 mg | 100 |
| 50 mg/ml | 250 ml |
We ask for your understanding that due to the Austrian Medicines Act, certain further information is only accessible to medical professionals.
Login
You are currently viewing a placeholder content from Facebook. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Instagram. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou need to load content from hCaptcha to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou need to load content from reCAPTCHA to submit the form. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from Turnstile. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More InformationYou are currently viewing a placeholder content from X. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.
More Information
